| Sierra Care Physicians, Amc | |
|
140 Litton Dr Ste 100 Grass Valley CA 95945-5078 | |
| (530) 477-4016 | |
| (530) 477-4018 |
| Full Name | Sierra Care Physicians, Amc |
|---|---|
| Speciality | Family Medicine |
| Location | 140 Litton Dr Ste 100, Grass Valley, California |
| Authorized Official Name and Position | Douglas E Wagner (PRESIDENT, BOARD OF DIRECTORS) |
| Authorized Official Contact | 5304774016 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Sierra Care Physicians, Amc P.o Box 459001 Grass Valley CA 95945-9109 Ph: (530) 477-4016 | Sierra Care Physicians, Amc 140 Litton Dr Ste 100 Grass Valley CA 95945-5078 Ph: (530) 477-4016 |
| NPI Number | 1427072008 |
|---|---|
| Provider Enumeration Date | 07/27/2006 |
| Last Update Date | 04/02/2012 |
| Medicare PECOS PAC ID | 8527000207 |
|---|---|
| Medicare Enrollment ID | O20050607000482 |
News Archive
The quadrennial guessing game about who will get what health job in a new presidential administration has taken on a new urgency in 2020 as the COVID-19 pandemic continues to rage.
Enginasion and TransCytos announced today that their collaboration has resulted in a prototype 'transfection' technology that is designed to have a dramatic and positive impact on the drug-research industry.
A new type of blood test for breast cancer could help avoid thousands of unnecessary surgeries and otherwise precisely monitor disease progression, according to a study led by the Translational Genomics Research Institute and Mayo Clinic in Arizona.
A recent study published in the Journal Emerging Microbes and Infections has highlighted the emergence of a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant with mutations in the membrane protein-encoding gene. Two potential mutations, M:I82T and M:V70L, have been identified within the transmembrane helices, which are expected to improve viral fitness by modulating glucose uptake during replication.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427072008 | NPI | - | NPPES |
| Provider Name | Andrew George Burt |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1902911845 PECOS PAC ID: 1557323250 Enrollment ID: I20041103000817 |
News Archive
The quadrennial guessing game about who will get what health job in a new presidential administration has taken on a new urgency in 2020 as the COVID-19 pandemic continues to rage.
Enginasion and TransCytos announced today that their collaboration has resulted in a prototype 'transfection' technology that is designed to have a dramatic and positive impact on the drug-research industry.
A new type of blood test for breast cancer could help avoid thousands of unnecessary surgeries and otherwise precisely monitor disease progression, according to a study led by the Translational Genomics Research Institute and Mayo Clinic in Arizona.
A recent study published in the Journal Emerging Microbes and Infections has highlighted the emergence of a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant with mutations in the membrane protein-encoding gene. Two potential mutations, M:I82T and M:V70L, have been identified within the transmembrane helices, which are expected to improve viral fitness by modulating glucose uptake during replication.
› Verified 8 days ago
| Provider Name | Mara Berezniak |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1770535585 PECOS PAC ID: 0840247417 Enrollment ID: I20050405001405 |
News Archive
The quadrennial guessing game about who will get what health job in a new presidential administration has taken on a new urgency in 2020 as the COVID-19 pandemic continues to rage.
Enginasion and TransCytos announced today that their collaboration has resulted in a prototype 'transfection' technology that is designed to have a dramatic and positive impact on the drug-research industry.
A new type of blood test for breast cancer could help avoid thousands of unnecessary surgeries and otherwise precisely monitor disease progression, according to a study led by the Translational Genomics Research Institute and Mayo Clinic in Arizona.
A recent study published in the Journal Emerging Microbes and Infections has highlighted the emergence of a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant with mutations in the membrane protein-encoding gene. Two potential mutations, M:I82T and M:V70L, have been identified within the transmembrane helices, which are expected to improve viral fitness by modulating glucose uptake during replication.
› Verified 8 days ago
| Provider Name | Huy A Nguyen |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1467400853 PECOS PAC ID: 9032156088 Enrollment ID: I20050412000681 |
News Archive
The quadrennial guessing game about who will get what health job in a new presidential administration has taken on a new urgency in 2020 as the COVID-19 pandemic continues to rage.
Enginasion and TransCytos announced today that their collaboration has resulted in a prototype 'transfection' technology that is designed to have a dramatic and positive impact on the drug-research industry.
A new type of blood test for breast cancer could help avoid thousands of unnecessary surgeries and otherwise precisely monitor disease progression, according to a study led by the Translational Genomics Research Institute and Mayo Clinic in Arizona.
A recent study published in the Journal Emerging Microbes and Infections has highlighted the emergence of a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant with mutations in the membrane protein-encoding gene. Two potential mutations, M:I82T and M:V70L, have been identified within the transmembrane helices, which are expected to improve viral fitness by modulating glucose uptake during replication.
› Verified 8 days ago
| Provider Name | Constance E Gaulter |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1508881459 PECOS PAC ID: 5496853863 Enrollment ID: I20070607000757 |
News Archive
The quadrennial guessing game about who will get what health job in a new presidential administration has taken on a new urgency in 2020 as the COVID-19 pandemic continues to rage.
Enginasion and TransCytos announced today that their collaboration has resulted in a prototype 'transfection' technology that is designed to have a dramatic and positive impact on the drug-research industry.
A new type of blood test for breast cancer could help avoid thousands of unnecessary surgeries and otherwise precisely monitor disease progression, according to a study led by the Translational Genomics Research Institute and Mayo Clinic in Arizona.
A recent study published in the Journal Emerging Microbes and Infections has highlighted the emergence of a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant with mutations in the membrane protein-encoding gene. Two potential mutations, M:I82T and M:V70L, have been identified within the transmembrane helices, which are expected to improve viral fitness by modulating glucose uptake during replication.
› Verified 8 days ago
| Provider Name | Karen A Greenhaw |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1649548686 PECOS PAC ID: 4981867900 Enrollment ID: I20120531000179 |
News Archive
The quadrennial guessing game about who will get what health job in a new presidential administration has taken on a new urgency in 2020 as the COVID-19 pandemic continues to rage.
Enginasion and TransCytos announced today that their collaboration has resulted in a prototype 'transfection' technology that is designed to have a dramatic and positive impact on the drug-research industry.
A new type of blood test for breast cancer could help avoid thousands of unnecessary surgeries and otherwise precisely monitor disease progression, according to a study led by the Translational Genomics Research Institute and Mayo Clinic in Arizona.
A recent study published in the Journal Emerging Microbes and Infections has highlighted the emergence of a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant with mutations in the membrane protein-encoding gene. Two potential mutations, M:I82T and M:V70L, have been identified within the transmembrane helices, which are expected to improve viral fitness by modulating glucose uptake during replication.
› Verified 8 days ago
| Provider Name | Linda M Mcintosh |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1497977219 PECOS PAC ID: 5193978146 Enrollment ID: I20121227000112 |
News Archive
The quadrennial guessing game about who will get what health job in a new presidential administration has taken on a new urgency in 2020 as the COVID-19 pandemic continues to rage.
Enginasion and TransCytos announced today that their collaboration has resulted in a prototype 'transfection' technology that is designed to have a dramatic and positive impact on the drug-research industry.
A new type of blood test for breast cancer could help avoid thousands of unnecessary surgeries and otherwise precisely monitor disease progression, according to a study led by the Translational Genomics Research Institute and Mayo Clinic in Arizona.
A recent study published in the Journal Emerging Microbes and Infections has highlighted the emergence of a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant with mutations in the membrane protein-encoding gene. Two potential mutations, M:I82T and M:V70L, have been identified within the transmembrane helices, which are expected to improve viral fitness by modulating glucose uptake during replication.
› Verified 8 days ago
| Provider Name | Dena N Dimond |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1518370519 PECOS PAC ID: 4880816974 Enrollment ID: I20141104002778 |
News Archive
The quadrennial guessing game about who will get what health job in a new presidential administration has taken on a new urgency in 2020 as the COVID-19 pandemic continues to rage.
Enginasion and TransCytos announced today that their collaboration has resulted in a prototype 'transfection' technology that is designed to have a dramatic and positive impact on the drug-research industry.
A new type of blood test for breast cancer could help avoid thousands of unnecessary surgeries and otherwise precisely monitor disease progression, according to a study led by the Translational Genomics Research Institute and Mayo Clinic in Arizona.
A recent study published in the Journal Emerging Microbes and Infections has highlighted the emergence of a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant with mutations in the membrane protein-encoding gene. Two potential mutations, M:I82T and M:V70L, have been identified within the transmembrane helices, which are expected to improve viral fitness by modulating glucose uptake during replication.
› Verified 8 days ago
| Provider Name | Pa Soua Xiong |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1386015220 PECOS PAC ID: 1355620063 Enrollment ID: I20181206002221 |
News Archive
The quadrennial guessing game about who will get what health job in a new presidential administration has taken on a new urgency in 2020 as the COVID-19 pandemic continues to rage.
Enginasion and TransCytos announced today that their collaboration has resulted in a prototype 'transfection' technology that is designed to have a dramatic and positive impact on the drug-research industry.
A new type of blood test for breast cancer could help avoid thousands of unnecessary surgeries and otherwise precisely monitor disease progression, according to a study led by the Translational Genomics Research Institute and Mayo Clinic in Arizona.
A recent study published in the Journal Emerging Microbes and Infections has highlighted the emergence of a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant with mutations in the membrane protein-encoding gene. Two potential mutations, M:I82T and M:V70L, have been identified within the transmembrane helices, which are expected to improve viral fitness by modulating glucose uptake during replication.
› Verified 8 days ago
News Archive
The quadrennial guessing game about who will get what health job in a new presidential administration has taken on a new urgency in 2020 as the COVID-19 pandemic continues to rage.
Enginasion and TransCytos announced today that their collaboration has resulted in a prototype 'transfection' technology that is designed to have a dramatic and positive impact on the drug-research industry.
A new type of blood test for breast cancer could help avoid thousands of unnecessary surgeries and otherwise precisely monitor disease progression, according to a study led by the Translational Genomics Research Institute and Mayo Clinic in Arizona.
A recent study published in the Journal Emerging Microbes and Infections has highlighted the emergence of a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant with mutations in the membrane protein-encoding gene. Two potential mutations, M:I82T and M:V70L, have been identified within the transmembrane helices, which are expected to improve viral fitness by modulating glucose uptake during replication.
› Verified 8 days ago
Dignity Health Medical Group - Sierra Nevada, A Service Of Dignity Hea Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 280 Sierra College Dr Ste 105, Grass Valley, CA 95945 Phone: 530-274-6727 | |
Western Sierra Medical Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 844 Old Tunnel Rd, Grass Valley, CA 95945 Phone: 530-273-4984 Fax: 530-273-4573 | |
Tracy Hawse Np Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 150 S Auburn St, Grass Valley, CA 95945 Phone: 530-613-1284 Fax: 866-247-1585 | |
Dana Marie Lewis, D.o., Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 10052 Alta Sierra Dr, Suite A, Grass Valley, CA 95949 Phone: 530-477-9100 Fax: 530-477-2033 | |
Regents Ucdmg Auburn Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 10044 Wolf Rd, #a, Grass Valley, CA 95949 Phone: 530-268-9050 | |
Western Sierra Medical Clinic, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 150 Glasson Way, Grass Valley, CA 95945 Phone: 530-273-4984 Fax: 530-273-4573 | |
Newsom & Fitzpatrick Medical Group Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 150 Catherine Ln, Suite G, Grass Valley, CA 95945 Phone: 530-271-2225 Fax: 530-271-7245 |